Strategic Growth Opportunities in Cardiovascular Interventional Product Markets, 2000-2010

“Cardiovascular disease” results from a number of possible conditions that inhibit the cardiovascular system from delivering an adequate blood flow and supply of oxygen and nutrients to organs and tissues of the body. Such conditions include the impaired pumping function of the heart muscle, distortion in the electrical activity of the heart, partial or complete obstruction of arterial and venous pathways, or some combination of myocardial, pacing and vascular deficiencies.